Chelation therapy is used as an adjunct therapy in Cancer treatments as one needs to evaluate the toxic load of a patient and those determinants to one’s immune, neurological and hormonal function in the interaction with cancer.
Chelation therapy is also used with patients with cardiovascular disease, such as atherosclerosis, diabetes and other circulatory diseases. It improves circulation by the removal of accumulated build up (plaques) that damage those vessels.
The study of chelation therapy was funded by the National Heart, Lung and Blood Institute and the National Center for Complementary and Alternative Medicine, from 2003 to 2007. The results of the study, published in the March 27, 2013 issue of the Journal of the America Medical Association (JAMA), found that patients who received chelation therapy had 18% fewer cardiovascular events defined as death, heart attack, stroke, coronary revascularization, and hospitalizations for angina compared to placebo. Diabetics appeared to particularly benefit, with a 39% reduction in cardiac events.
Dr. Goldberg worked at a satellite clinic in Napa, Califronia, where this study was performed and administered therapies as part of this study!!
The results are encouraging and hopefully will lead to further evaluation of chelation therapy as a useful adjunct in the management of cardiovascular disease.